|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Tradename: OPTISON
Summary for Tradename: OPTISON
|
| |||||||||
Clinical Trials for: OPTISONA Prospective Surveillance Trial to Evaluate the Safety of Optison in Clinical Practice. Status: Completed Condition: Echocardiography Regadenoson Real Time Perfusion Imaging Trial-Optison Status: Recruiting Condition: Coronary Artery Disease; Myocardial Perfusion Abnormalities Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors Status: Completed Condition: Abdominal Neoplasms; Pelvic Neoplasms Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pulmonary Vascular Resistance (PVR). Status: Completed Condition: Pulmonary Hypertension Dose-Finding, Feasibility Study of Optison in Contrast Enhanced U/S for the Detection of Carotid Artery Disease Status: Terminated Condition: Carotid Artery Disease Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial Appendage Status: Not yet recruiting Condition: Atrial Fibrillation Contrast Enhanced Ultrasound for Evaluation of Pediatric Abdominal Trauma Status: Not yet recruiting Condition: Abdominal Trauma Pre-operative Evaluation of Kidney & Pancreas Transplant Patients Status: Active, not recruiting Condition: Kidney Transplantation; Pancreas Transplantation Detection of Coronary Stenosis With Intravenous Microbubbles Status: Withdrawn Condition: Coronary Stenosis; Carotid Stenosis; Myocardial Reperfusion Assessing Myocardial Blood Flow and Blood Flow Reserve by Transoesophageal Echocardiography (TEE) Status: Withdrawn Condition: Coronary Artery Disease Courtesy of ClinicalTrials.org See more clinical trials for this drug | ||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Exclusivity Expiration | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ge Healthcare | OPTISON | albumin human | INJECTABLE; INJECTION | 020899 | Dec 31, 1997 | RX | Yes | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ge Healthcare | OPTISON | albumin human | INJECTABLE; INJECTION | 020899 | Dec 31, 1997 | RX | Yes | 5,529,766 | <disabled> | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ge Healthcare | OPTISON | albumin human | INJECTABLE; INJECTION | 020899 | Dec 31, 1997 | RX | Yes | 6,723,303 | Y | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
DrugPatentWatch Archives
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc